nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.152	0.273	CbGbCtD
Methazolamide—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0919	0.166	CbGbCtD
Methazolamide—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0742	0.134	CbGbCtD
Methazolamide—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0575	0.104	CbGbCtD
Methazolamide—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0534	0.0964	CbGbCtD
Methazolamide—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0394	0.071	CbGbCtD
Methazolamide—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0245	0.0442	CbGbCtD
Methazolamide—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0241	0.0435	CbGbCtD
Methazolamide—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0225	0.0405	CbGbCtD
Methazolamide—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0153	0.0277	CbGbCtD
Methazolamide—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00168	0.00376	CcSEcCtD
Methazolamide—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00168	0.00376	CcSEcCtD
Methazolamide—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00168	0.00376	CcSEcCtD
Methazolamide—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00166	0.00373	CcSEcCtD
Methazolamide—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00166	0.00373	CcSEcCtD
Methazolamide—Tinnitus—Alitretinoin—peripheral nervous system neoplasm	0.00165	0.00371	CcSEcCtD
Methazolamide—Pancytopenia—Etoposide—peripheral nervous system neoplasm	0.00164	0.00369	CcSEcCtD
Methazolamide—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00164	0.00368	CcSEcCtD
Methazolamide—Anorexia—Topotecan—peripheral nervous system neoplasm	0.0016	0.00359	CcSEcCtD
Methazolamide—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.00158	0.00356	CcSEcCtD
Methazolamide—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.00158	0.00356	CcSEcCtD
Methazolamide—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00156	0.00351	CcSEcCtD
Methazolamide—Ill-defined disorder—Dactinomycin—peripheral nervous system neoplasm	0.00154	0.00347	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.00153	0.00343	CcSEcCtD
Methazolamide—Melaena—Epirubicin—peripheral nervous system neoplasm	0.00151	0.00339	CcSEcCtD
Methazolamide—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.0015	0.00338	CcSEcCtD
Methazolamide—Malaise—Dactinomycin—peripheral nervous system neoplasm	0.0015	0.00337	CcSEcCtD
Methazolamide—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00149	0.00335	CcSEcCtD
Methazolamide—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00149	0.00335	CcSEcCtD
Methazolamide—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00149	0.00335	CcSEcCtD
Methazolamide—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00148	0.00332	CcSEcCtD
Methazolamide—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00148	0.00332	CcSEcCtD
Methazolamide—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00147	0.00331	CcSEcCtD
Methazolamide—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00147	0.00331	CcSEcCtD
Methazolamide—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00146	0.00329	CcSEcCtD
Methazolamide—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00146	0.00329	CcSEcCtD
Methazolamide—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00146	0.00327	CcSEcCtD
Methazolamide—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.00145	0.00326	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00145	0.00325	CcSEcCtD
Methazolamide—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00144	0.00324	CcSEcCtD
Methazolamide—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00144	0.00324	CcSEcCtD
Methazolamide—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00144	0.00324	CcSEcCtD
Methazolamide—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00144	0.00324	CcSEcCtD
Methazolamide—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00144	0.00323	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00143	0.00322	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00143	0.00322	CcSEcCtD
Methazolamide—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00143	0.00322	CcSEcCtD
Methazolamide—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00143	0.00322	CcSEcCtD
Methazolamide—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.00143	0.00322	CcSEcCtD
Methazolamide—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00143	0.0032	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00142	0.00318	CcSEcCtD
Methazolamide—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00141	0.00318	CcSEcCtD
Methazolamide—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.00141	0.00316	CcSEcCtD
Methazolamide—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.0014	0.00314	CcSEcCtD
Methazolamide—Melaena—Doxorubicin—peripheral nervous system neoplasm	0.0014	0.00314	CcSEcCtD
Methazolamide—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.00139	0.00313	CcSEcCtD
Methazolamide—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00138	0.0031	CcSEcCtD
Methazolamide—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00137	0.00308	CcSEcCtD
Methazolamide—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00137	0.00308	CcSEcCtD
Methazolamide—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00134	0.00301	CcSEcCtD
Methazolamide—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00134	0.003	CcSEcCtD
Methazolamide—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00134	0.003	CcSEcCtD
Methazolamide—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00133	0.00299	CcSEcCtD
Methazolamide—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00133	0.00299	CcSEcCtD
Methazolamide—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00132	0.00297	CcSEcCtD
Methazolamide—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00132	0.00296	CcSEcCtD
Methazolamide—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00132	0.00296	CcSEcCtD
Methazolamide—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00131	0.00295	CcSEcCtD
Methazolamide—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00131	0.00295	CcSEcCtD
Methazolamide—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00131	0.00294	CcSEcCtD
Methazolamide—Urticaria—Melphalan—peripheral nervous system neoplasm	0.0013	0.00293	CcSEcCtD
Methazolamide—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.0013	0.00292	CcSEcCtD
Methazolamide—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00129	0.00291	CcSEcCtD
Methazolamide—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00129	0.00289	CcSEcCtD
Methazolamide—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.00128	0.00287	CcSEcCtD
Methazolamide—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.00285	CcSEcCtD
Methazolamide—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00126	0.00283	CcSEcCtD
Methazolamide—Hepatic failure—Epirubicin—peripheral nervous system neoplasm	0.00125	0.0028	CcSEcCtD
Methazolamide—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00122	0.00274	CcSEcCtD
Methazolamide—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00121	0.00273	CcSEcCtD
Methazolamide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.0012	0.0027	CcSEcCtD
Methazolamide—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.0012	0.0027	CcSEcCtD
Methazolamide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00119	0.00268	CcSEcCtD
Methazolamide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00119	0.00268	CcSEcCtD
Methazolamide—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00266	CcSEcCtD
Methazolamide—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00118	0.00265	CcSEcCtD
Methazolamide—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00118	0.00265	CcSEcCtD
Methazolamide—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00118	0.00265	CcSEcCtD
Methazolamide—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00118	0.00264	CcSEcCtD
Methazolamide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00118	0.00264	CcSEcCtD
Methazolamide—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00117	0.00263	CcSEcCtD
Methazolamide—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00116	0.0026	CcSEcCtD
Methazolamide—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00259	CcSEcCtD
Methazolamide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00115	0.00257	CcSEcCtD
Methazolamide—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00114	0.00256	CcSEcCtD
Methazolamide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00114	0.00255	CcSEcCtD
Methazolamide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00114	0.00255	CcSEcCtD
Methazolamide—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00113	0.00254	CcSEcCtD
Methazolamide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00112	0.00252	CcSEcCtD
Methazolamide—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00112	0.00251	CcSEcCtD
Methazolamide—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00112	0.00251	CcSEcCtD
Methazolamide—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00112	0.00251	CcSEcCtD
Methazolamide—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00111	0.00249	CcSEcCtD
Methazolamide—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00111	0.00248	CcSEcCtD
Methazolamide—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00246	CcSEcCtD
Methazolamide—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00109	0.00245	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00244	CcSEcCtD
Methazolamide—Malaise—Etoposide—peripheral nervous system neoplasm	0.00109	0.00244	CcSEcCtD
Methazolamide—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00244	CcSEcCtD
Methazolamide—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00108	0.00243	CcSEcCtD
Methazolamide—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00108	0.00242	CcSEcCtD
Methazolamide—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00107	0.00241	CcSEcCtD
Methazolamide—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00107	0.00241	CcSEcCtD
Methazolamide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00107	0.00239	CcSEcCtD
Methazolamide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00106	0.00237	CcSEcCtD
Methazolamide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00106	0.00237	CcSEcCtD
Methazolamide—Rash—Topotecan—peripheral nervous system neoplasm	0.00106	0.00237	CcSEcCtD
Methazolamide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00106	0.00237	CcSEcCtD
Methazolamide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00106	0.00237	CcSEcCtD
Methazolamide—Headache—Topotecan—peripheral nervous system neoplasm	0.00105	0.00236	CcSEcCtD
Methazolamide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00105	0.00235	CcSEcCtD
Methazolamide—Rash—Tretinoin—peripheral nervous system neoplasm	0.00105	0.00235	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00105	0.00235	CcSEcCtD
Methazolamide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00105	0.00235	CcSEcCtD
Methazolamide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00105	0.00235	CcSEcCtD
Methazolamide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00105	0.00235	CcSEcCtD
Methazolamide—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00104	0.00234	CcSEcCtD
Methazolamide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00104	0.00234	CcSEcCtD
Methazolamide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00104	0.00234	CcSEcCtD
Methazolamide—Headache—Tretinoin—peripheral nervous system neoplasm	0.00104	0.00234	CcSEcCtD
Methazolamide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00104	0.00233	CcSEcCtD
Methazolamide—Rash—Melphalan—peripheral nervous system neoplasm	0.00103	0.00232	CcSEcCtD
Methazolamide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00103	0.00232	CcSEcCtD
Methazolamide—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00102	0.0023	CcSEcCtD
Methazolamide—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00101	0.00228	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00227	CcSEcCtD
Methazolamide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.001	0.00225	CcSEcCtD
Methazolamide—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000996	0.00224	CcSEcCtD
Methazolamide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000995	0.00223	CcSEcCtD
Methazolamide—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000991	0.00223	CcSEcCtD
Methazolamide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000987	0.00222	CcSEcCtD
Methazolamide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000987	0.00222	CcSEcCtD
Methazolamide—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000983	0.00221	CcSEcCtD
Methazolamide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000975	0.00219	CcSEcCtD
Methazolamide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000974	0.00219	CcSEcCtD
Methazolamide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000964	0.00216	CcSEcCtD
Methazolamide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000959	0.00215	CcSEcCtD
Methazolamide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000937	0.0021	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000934	0.0021	CcSEcCtD
Methazolamide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000933	0.00209	CcSEcCtD
Methazolamide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000929	0.00209	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000927	0.00208	CcSEcCtD
Methazolamide—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00092	0.00207	CcSEcCtD
Methazolamide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000904	0.00203	CcSEcCtD
Methazolamide—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000885	0.00199	CcSEcCtD
Methazolamide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000884	0.00199	CcSEcCtD
Methazolamide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000883	0.00198	CcSEcCtD
Methazolamide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000874	0.00196	CcSEcCtD
Methazolamide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000871	0.00196	CcSEcCtD
Methazolamide—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000864	0.00194	CcSEcCtD
Methazolamide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000864	0.00194	CcSEcCtD
Methazolamide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000862	0.00194	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000857	0.00192	CcSEcCtD
Methazolamide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000857	0.00192	CcSEcCtD
Methazolamide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000855	0.00192	CcSEcCtD
Methazolamide—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000852	0.00191	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000849	0.00191	CcSEcCtD
Methazolamide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000848	0.00191	CcSEcCtD
Methazolamide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000848	0.0019	CcSEcCtD
Methazolamide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00083	0.00186	CcSEcCtD
Methazolamide—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000824	0.00185	CcSEcCtD
Methazolamide—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000819	0.00184	CcSEcCtD
Methazolamide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00081	0.00182	CcSEcCtD
Methazolamide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000807	0.00181	CcSEcCtD
Methazolamide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000806	0.00181	CcSEcCtD
Methazolamide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000801	0.0018	CcSEcCtD
Methazolamide—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.0008	0.0018	CcSEcCtD
Methazolamide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000794	0.00178	CcSEcCtD
Methazolamide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000793	0.00178	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000793	0.00178	CcSEcCtD
Methazolamide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000789	0.00177	CcSEcCtD
Methazolamide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000781	0.00175	CcSEcCtD
Methazolamide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000777	0.00175	CcSEcCtD
Methazolamide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000772	0.00173	CcSEcCtD
Methazolamide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00077	0.00173	CcSEcCtD
Methazolamide—Rash—Vincristine—peripheral nervous system neoplasm	0.000765	0.00172	CcSEcCtD
Methazolamide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000765	0.00172	CcSEcCtD
Methazolamide—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000762	0.00171	CcSEcCtD
Methazolamide—Headache—Vincristine—peripheral nervous system neoplasm	0.00076	0.00171	CcSEcCtD
Methazolamide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000748	0.00168	CcSEcCtD
Methazolamide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000746	0.00168	CcSEcCtD
Methazolamide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000734	0.00165	CcSEcCtD
Methazolamide—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000733	0.00165	CcSEcCtD
Methazolamide—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000723	0.00162	CcSEcCtD
Methazolamide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000721	0.00162	CcSEcCtD
Methazolamide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000705	0.00158	CcSEcCtD
Methazolamide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000682	0.00153	CcSEcCtD
Methazolamide—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000679	0.00152	CcSEcCtD
Methazolamide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000677	0.00152	CcSEcCtD
Methazolamide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000676	0.00152	CcSEcCtD
Methazolamide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000673	0.00151	CcSEcCtD
Methazolamide—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000669	0.0015	CcSEcCtD
Methazolamide—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000661	0.00148	CcSEcCtD
Methazolamide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000637	0.00143	CcSEcCtD
Methazolamide—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000627	0.00141	CcSEcCtD
Methazolamide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000625	0.0014	CcSEcCtD
Methazolamide—Rash—Etoposide—peripheral nervous system neoplasm	0.00062	0.00139	CcSEcCtD
Methazolamide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000619	0.00139	CcSEcCtD
Methazolamide—Headache—Etoposide—peripheral nervous system neoplasm	0.000616	0.00138	CcSEcCtD
Methazolamide—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000612	0.00137	CcSEcCtD
Methazolamide—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000609	0.00137	CcSEcCtD
Methazolamide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000607	0.00136	CcSEcCtD
Methazolamide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000604	0.00136	CcSEcCtD
Methazolamide—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000585	0.00131	CcSEcCtD
Methazolamide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000584	0.00131	CcSEcCtD
Methazolamide—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.00058	0.0013	CcSEcCtD
Methazolamide—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000568	0.00128	CcSEcCtD
Methazolamide—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000563	0.00127	CcSEcCtD
Methazolamide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000561	0.00126	CcSEcCtD
Methazolamide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000559	0.00126	CcSEcCtD
Methazolamide—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000556	0.00125	CcSEcCtD
Methazolamide—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000551	0.00124	CcSEcCtD
Methazolamide—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000541	0.00122	CcSEcCtD
Methazolamide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000526	0.00118	CcSEcCtD
Methazolamide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000525	0.00118	CcSEcCtD
Methazolamide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000514	0.00115	CcSEcCtD
Methazolamide—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00051	0.00115	CcSEcCtD
Methazolamide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000495	0.00111	CcSEcCtD
Methazolamide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00049	0.0011	CcSEcCtD
Methazolamide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000486	0.00109	CcSEcCtD
Methazolamide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000485	0.00109	CcSEcCtD
Methazolamide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000479	0.00108	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000476	0.00107	CcSEcCtD
Methazolamide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000475	0.00107	CcSEcCtD
Methazolamide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000458	0.00103	CcSEcCtD
Methazolamide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000454	0.00102	CcSEcCtD
Methazolamide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.00102	CcSEcCtD
Methazolamide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000449	0.00101	CcSEcCtD
Methazolamide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.000995	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00044	0.000989	CcSEcCtD
Methazolamide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00044	0.000987	CcSEcCtD
Methazolamide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000438	0.000983	CcSEcCtD
Methazolamide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000436	0.000978	CcSEcCtD
Methazolamide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.000944	CcSEcCtD
Methazolamide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000405	0.00091	CcSEcCtD
Methazolamide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.000905	CcSEcCtD
Methazolamide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000395	0.000888	CcSEcCtD
Methazolamide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000377	0.000847	CcSEcCtD
Methazolamide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.000822	CcSEcCtD
Methazolamide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00035	0.000787	CcSEcCtD
Methazolamide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000784	CcSEcCtD
Methazolamide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000347	0.00078	CcSEcCtD
Methazolamide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000347	0.00078	CcSEcCtD
Methazolamide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000775	CcSEcCtD
Methazolamide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000327	0.000735	CcSEcCtD
Methazolamide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000728	CcSEcCtD
Methazolamide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.000722	CcSEcCtD
Methazolamide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000721	CcSEcCtD
Methazolamide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000717	CcSEcCtD
Methazolamide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.00068	CcSEcCtD
